カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のチロシンプロテインキナーゼマー市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Tyrosine Protein Kinase Mer Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19681）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19681
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：113
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のチロシンプロテインキナーゼマー市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

チロシンプロテインキナーゼマー市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のチロシンプロテインキナーゼマーの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

チロシンプロテインキナーゼマー市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・プロトオンコジーンcマー、受容体チロシンキナーゼマーTK、MERTK、EC 2.7.10.1

用途別セグメントは次のように区分されます。
・腫瘍学、眼科

世界のチロシンプロテインキナーゼマー市場の主要な市場プレーヤーは以下のとおりです。
・Celldex Therapeutics Inc、Celon Pharma SA、Dong-A Socio Holdings Co Ltd、Eli Lilly and Co、F. Hoffmann-La Roche Ltd、HEC Pharma Co Ltd、Hope Biosciences Inc、Incyte Corp、Mediolanum farmaceutici SpA、Meryx Inc、Mirati Therapeutics Inc、Ono Pharmaceutical Co Ltd、Pfizer Inc、Qurient Co Ltd、Rgenix Inc、SignalChem Lifesciences Corp

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、チロシンプロテインキナーゼマー製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なチロシンプロテインキナーゼマーメーカーの企業概要、2019年～2022年までのチロシンプロテインキナーゼマーの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なチロシンプロテインキナーゼマーメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別チロシンプロテインキナーゼマーの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのチロシンプロテインキナーゼマーの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのチロシンプロテインキナーゼマー市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびチロシンプロテインキナーゼマーの産業チェーンを掲載しています。
・第13、14、15章では、チロシンプロテインキナーゼマーの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- チロシンプロテインキナーゼマーの概要
- 種類別分析（2017年vs2021年vs2028年）：プロトオンコジーンcマー、受容体チロシンキナーゼマーTK、MERTK、EC 2.7.10.1
- 用途別分析（2017年vs2021年vs2028年）：腫瘍学、眼科
- 世界のチロシンプロテインキナーゼマー市場規模・予測
- 世界のチロシンプロテインキナーゼマー生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Celldex Therapeutics Inc、Celon Pharma SA、Dong-A Socio Holdings Co Ltd、Eli Lilly and Co、F. Hoffmann-La Roche Ltd、HEC Pharma Co Ltd、Hope Biosciences Inc、Incyte Corp、Mediolanum farmaceutici SpA、Meryx Inc、Mirati Therapeutics Inc、Ono Pharmaceutical Co Ltd、Pfizer Inc、Qurient Co Ltd、Rgenix Inc、SignalChem Lifesciences Corp
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：プロトオンコジーンcマー、受容体チロシンキナーゼマーTK、MERTK、EC 2.7.10.1
・用途別分析2017年-2028年：腫瘍学、眼科
・チロシンプロテインキナーゼマーの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・チロシンプロテインキナーゼマーのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・チロシンプロテインキナーゼマーのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・チロシンプロテインキナーゼマーの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・チロシンプロテインキナーゼマーの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Tyrosine Protein Kinase Mer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tyrosine Protein Kinase Mer market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Oncology accounting for % of the Tyrosine Protein Kinase Mer global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Proto Oncogene c Mer segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tyrosine Protein Kinase Mer include Celldex Therapeutics Inc, Celon Pharma SA, Dong-A Socio Holdings Co Ltd, Eli Lilly and Co, and F. Hoffmann-La Roche Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tyrosine Protein Kinase Mer market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Proto Oncogene c Mer
Receptor Tyrosine Kinase MerTK
MERTK
EC 2.7.10.1
Market segment by Application can be divided into
Oncology
Ophthalmology
The key market players for global Tyrosine Protein Kinase Mer market are listed below:
Celldex Therapeutics Inc
Celon Pharma SA
Dong-A Socio Holdings Co Ltd
Eli Lilly and Co
F. Hoffmann-La Roche Ltd
HEC Pharma Co Ltd
Hope Biosciences Inc
Incyte Corp
Mediolanum farmaceutici SpA
Meryx Inc
Mirati Therapeutics Inc
Ono Pharmaceutical Co Ltd
Pfizer Inc
Qurient Co Ltd
Rgenix Inc
SignalChem Lifesciences Corp
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tyrosine Protein Kinase Mer product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tyrosine Protein Kinase Mer, with price, sales, revenue and global market share of Tyrosine Protein Kinase Mer from 2019 to 2022.
Chapter 3, the Tyrosine Protein Kinase Mer competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tyrosine Protein Kinase Mer breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tyrosine Protein Kinase Mer market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tyrosine Protein Kinase Mer.
Chapter 13, 14, and 15, to describe Tyrosine Protein Kinase Mer sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Tyrosine Protein Kinase Mer Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tyrosine Protein Kinase Mer Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Proto Oncogene c Mer
1.2.3 Receptor Tyrosine Kinase MerTK
1.2.4 MERTK
1.2.5 EC 2.7.10.1
1.3 Market Analysis by Application
1.3.1 Overview: Global Tyrosine Protein Kinase Mer Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Ophthalmology
1.4 Global Tyrosine Protein Kinase Mer Market Size & Forecast
1.4.1 Global Tyrosine Protein Kinase Mer Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Tyrosine Protein Kinase Mer Sales in Volume (2017-2028)
1.4.3 Global Tyrosine Protein Kinase Mer Price (2017-2028)
1.5 Global Tyrosine Protein Kinase Mer Production Capacity Analysis
1.5.1 Global Tyrosine Protein Kinase Mer Total Production Capacity (2017-2028)
1.5.2 Global Tyrosine Protein Kinase Mer Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tyrosine Protein Kinase Mer Market Drivers
1.6.2 Tyrosine Protein Kinase Mer Market Restraints
1.6.3 Tyrosine Protein Kinase Mer Trends Analysis
2 Manufacturers Profiles
2.1 Celldex Therapeutics Inc
2.1.1 Celldex Therapeutics Inc Details
2.1.2 Celldex Therapeutics Inc Major Business
2.1.3 Celldex Therapeutics Inc Tyrosine Protein Kinase Mer Product and Services
2.1.4 Celldex Therapeutics Inc Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Celon Pharma SA
2.2.1 Celon Pharma SA Details
2.2.2 Celon Pharma SA Major Business
2.2.3 Celon Pharma SA Tyrosine Protein Kinase Mer Product and Services
2.2.4 Celon Pharma SA Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Dong-A Socio Holdings Co Ltd
2.3.1 Dong-A Socio Holdings Co Ltd Details
2.3.2 Dong-A Socio Holdings Co Ltd Major Business
2.3.3 Dong-A Socio Holdings Co Ltd Tyrosine Protein Kinase Mer Product and Services
2.3.4 Dong-A Socio Holdings Co Ltd Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Eli Lilly and Co
2.4.1 Eli Lilly and Co Details
2.4.2 Eli Lilly and Co Major Business
2.4.3 Eli Lilly and Co Tyrosine Protein Kinase Mer Product and Services
2.4.4 Eli Lilly and Co Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 F. Hoffmann-La Roche Ltd
2.5.1 F. Hoffmann-La Roche Ltd Details
2.5.2 F. Hoffmann-La Roche Ltd Major Business
2.5.3 F. Hoffmann-La Roche Ltd Tyrosine Protein Kinase Mer Product and Services
2.5.4 F. Hoffmann-La Roche Ltd Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 HEC Pharma Co Ltd
2.6.1 HEC Pharma Co Ltd Details
2.6.2 HEC Pharma Co Ltd Major Business
2.6.3 HEC Pharma Co Ltd Tyrosine Protein Kinase Mer Product and Services
2.6.4 HEC Pharma Co Ltd Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hope Biosciences Inc
2.7.1 Hope Biosciences Inc Details
2.7.2 Hope Biosciences Inc Major Business
2.7.3 Hope Biosciences Inc Tyrosine Protein Kinase Mer Product and Services
2.7.4 Hope Biosciences Inc Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Incyte Corp
2.8.1 Incyte Corp Details
2.8.2 Incyte Corp Major Business
2.8.3 Incyte Corp Tyrosine Protein Kinase Mer Product and Services
2.8.4 Incyte Corp Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Mediolanum farmaceutici SpA
2.9.1 Mediolanum farmaceutici SpA Details
2.9.2 Mediolanum farmaceutici SpA Major Business
2.9.3 Mediolanum farmaceutici SpA Tyrosine Protein Kinase Mer Product and Services
2.9.4 Mediolanum farmaceutici SpA Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Meryx Inc
2.10.1 Meryx Inc Details
2.10.2 Meryx Inc Major Business
2.10.3 Meryx Inc Tyrosine Protein Kinase Mer Product and Services
2.10.4 Meryx Inc Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Mirati Therapeutics Inc
2.11.1 Mirati Therapeutics Inc Details
2.11.2 Mirati Therapeutics Inc Major Business
2.11.3 Mirati Therapeutics Inc Tyrosine Protein Kinase Mer Product and Services
2.11.4 Mirati Therapeutics Inc Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Ono Pharmaceutical Co Ltd
2.12.1 Ono Pharmaceutical Co Ltd Details
2.12.2 Ono Pharmaceutical Co Ltd Major Business
2.12.3 Ono Pharmaceutical Co Ltd Tyrosine Protein Kinase Mer Product and Services
2.12.4 Ono Pharmaceutical Co Ltd Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Pfizer Inc
2.13.1 Pfizer Inc Details
2.13.2 Pfizer Inc Major Business
2.13.3 Pfizer Inc Tyrosine Protein Kinase Mer Product and Services
2.13.4 Pfizer Inc Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Qurient Co Ltd
2.14.1 Qurient Co Ltd Details
2.14.2 Qurient Co Ltd Major Business
2.14.3 Qurient Co Ltd Tyrosine Protein Kinase Mer Product and Services
2.14.4 Qurient Co Ltd Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Rgenix Inc
2.15.1 Rgenix Inc Details
2.15.2 Rgenix Inc Major Business
2.15.3 Rgenix Inc Tyrosine Protein Kinase Mer Product and Services
2.15.4 Rgenix Inc Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 SignalChem Lifesciences Corp
2.16.1 SignalChem Lifesciences Corp Details
2.16.2 SignalChem Lifesciences Corp Major Business
2.16.3 SignalChem Lifesciences Corp Tyrosine Protein Kinase Mer Product and Services
2.16.4 SignalChem Lifesciences Corp Tyrosine Protein Kinase Mer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Tyrosine Protein Kinase Mer Breakdown Data by Manufacturer
3.1 Global Tyrosine Protein Kinase Mer Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Tyrosine Protein Kinase Mer Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Tyrosine Protein Kinase Mer
3.4 Market Concentration Rate
3.4.1 Top 3 Tyrosine Protein Kinase Mer Manufacturer Market Share in 2021
3.4.2 Top 6 Tyrosine Protein Kinase Mer Manufacturer Market Share in 2021
3.5 Global Tyrosine Protein Kinase Mer Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Tyrosine Protein Kinase Mer Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tyrosine Protein Kinase Mer Market Size by Region
4.1.1 Global Tyrosine Protein Kinase Mer Sales in Volume by Region (2017-2028)
4.1.2 Global Tyrosine Protein Kinase Mer Revenue by Region (2017-2028)
4.2 North America Tyrosine Protein Kinase Mer Revenue (2017-2028)
4.3 Europe Tyrosine Protein Kinase Mer Revenue (2017-2028)
4.4 Asia-Pacific Tyrosine Protein Kinase Mer Revenue (2017-2028)
4.5 South America Tyrosine Protein Kinase Mer Revenue (2017-2028)
4.6 Middle East and Africa Tyrosine Protein Kinase Mer Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Tyrosine Protein Kinase Mer Sales in Volume by Type (2017-2028)
5.2 Global Tyrosine Protein Kinase Mer Revenue by Type (2017-2028)
5.3 Global Tyrosine Protein Kinase Mer Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Tyrosine Protein Kinase Mer Sales in Volume by Application (2017-2028)
6.2 Global Tyrosine Protein Kinase Mer Revenue by Application (2017-2028)
6.3 Global Tyrosine Protein Kinase Mer Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Tyrosine Protein Kinase Mer Sales by Type (2017-2028)
7.2 North America Tyrosine Protein Kinase Mer Sales by Application (2017-2028)
7.3 North America Tyrosine Protein Kinase Mer Market Size by Country
7.3.1 North America Tyrosine Protein Kinase Mer Sales in Volume by Country (2017-2028)
7.3.2 North America Tyrosine Protein Kinase Mer Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Tyrosine Protein Kinase Mer Sales by Type (2017-2028)
8.2 Europe Tyrosine Protein Kinase Mer Sales by Application (2017-2028)
8.3 Europe Tyrosine Protein Kinase Mer Market Size by Country
8.3.1 Europe Tyrosine Protein Kinase Mer Sales in Volume by Country (2017-2028)
8.3.2 Europe Tyrosine Protein Kinase Mer Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Tyrosine Protein Kinase Mer Sales by Type (2017-2028)
9.2 Asia-Pacific Tyrosine Protein Kinase Mer Sales by Application (2017-2028)
9.3 Asia-Pacific Tyrosine Protein Kinase Mer Market Size by Region
9.3.1 Asia-Pacific Tyrosine Protein Kinase Mer Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Tyrosine Protein Kinase Mer Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Tyrosine Protein Kinase Mer Sales by Type (2017-2028)
10.2 South America Tyrosine Protein Kinase Mer Sales by Application (2017-2028)
10.3 South America Tyrosine Protein Kinase Mer Market Size by Country
10.3.1 South America Tyrosine Protein Kinase Mer Sales in Volume by Country (2017-2028)
10.3.2 South America Tyrosine Protein Kinase Mer Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tyrosine Protein Kinase Mer Sales by Type (2017-2028)
11.2 Middle East & Africa Tyrosine Protein Kinase Mer Sales by Application (2017-2028)
11.3 Middle East & Africa Tyrosine Protein Kinase Mer Market Size by Country
11.3.1 Middle East & Africa Tyrosine Protein Kinase Mer Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Tyrosine Protein Kinase Mer Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Tyrosine Protein Kinase Mer and Key Manufacturers
12.2 Manufacturing Costs Percentage of Tyrosine Protein Kinase Mer
12.3 Tyrosine Protein Kinase Mer Production Process
12.4 Tyrosine Protein Kinase Mer Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Tyrosine Protein Kinase Mer Typical Distributors
13.3 Tyrosine Protein Kinase Mer Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Tyrosine Protein Kinase Mer Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Tyrosine Protein Kinase Mer Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Celldex Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 4. Celldex Therapeutics Inc Major Business
Table 5. Celldex Therapeutics Inc Tyrosine Protein Kinase Mer Product and Services
Table 6. Celldex Therapeutics Inc Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Celon Pharma SA Basic Information, Manufacturing Base and Competitors
Table 8. Celon Pharma SA Major Business
Table 9. Celon Pharma SA Tyrosine Protein Kinase Mer Product and Services
Table 10. Celon Pharma SA Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Dong-A Socio Holdings Co Ltd Basic Information, Manufacturing Base and Competitors
Table 12. Dong-A Socio Holdings Co Ltd Major Business
Table 13. Dong-A Socio Holdings Co Ltd Tyrosine Protein Kinase Mer Product and Services
Table 14. Dong-A Socio Holdings Co Ltd Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Eli Lilly and Co Basic Information, Manufacturing Base and Competitors
Table 16. Eli Lilly and Co Major Business
Table 17. Eli Lilly and Co Tyrosine Protein Kinase Mer Product and Services
Table 18. Eli Lilly and Co Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 20. F. Hoffmann-La Roche Ltd Major Business
Table 21. F. Hoffmann-La Roche Ltd Tyrosine Protein Kinase Mer Product and Services
Table 22. F. Hoffmann-La Roche Ltd Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. HEC Pharma Co Ltd Basic Information, Manufacturing Base and Competitors
Table 24. HEC Pharma Co Ltd Major Business
Table 25. HEC Pharma Co Ltd Tyrosine Protein Kinase Mer Product and Services
Table 26. HEC Pharma Co Ltd Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hope Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 28. Hope Biosciences Inc Major Business
Table 29. Hope Biosciences Inc Tyrosine Protein Kinase Mer Product and Services
Table 30. Hope Biosciences Inc Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Incyte Corp Basic Information, Manufacturing Base and Competitors
Table 32. Incyte Corp Major Business
Table 33. Incyte Corp Tyrosine Protein Kinase Mer Product and Services
Table 34. Incyte Corp Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Mediolanum farmaceutici SpA Basic Information, Manufacturing Base and Competitors
Table 36. Mediolanum farmaceutici SpA Major Business
Table 37. Mediolanum farmaceutici SpA Tyrosine Protein Kinase Mer Product and Services
Table 38. Mediolanum farmaceutici SpA Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Meryx Inc Basic Information, Manufacturing Base and Competitors
Table 40. Meryx Inc Major Business
Table 41. Meryx Inc Tyrosine Protein Kinase Mer Product and Services
Table 42. Meryx Inc Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Mirati Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 44. Mirati Therapeutics Inc Major Business
Table 45. Mirati Therapeutics Inc Tyrosine Protein Kinase Mer Product and Services
Table 46. Mirati Therapeutics Inc Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Ono Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 48. Ono Pharmaceutical Co Ltd Major Business
Table 49. Ono Pharmaceutical Co Ltd Tyrosine Protein Kinase Mer Product and Services
Table 50. Ono Pharmaceutical Co Ltd Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 52. Pfizer Inc Major Business
Table 53. Pfizer Inc Tyrosine Protein Kinase Mer Product and Services
Table 54. Pfizer Inc Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Qurient Co Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Qurient Co Ltd Major Business
Table 57. Qurient Co Ltd Tyrosine Protein Kinase Mer Product and Services
Table 58. Qurient Co Ltd Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Rgenix Inc Basic Information, Manufacturing Base and Competitors
Table 60. Rgenix Inc Major Business
Table 61. Rgenix Inc Tyrosine Protein Kinase Mer Product and Services
Table 62. Rgenix Inc Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. SignalChem Lifesciences Corp Basic Information, Manufacturing Base and Competitors
Table 64. SignalChem Lifesciences Corp Major Business
Table 65. SignalChem Lifesciences Corp Tyrosine Protein Kinase Mer Product and Services
Table 66. SignalChem Lifesciences Corp Tyrosine Protein Kinase Mer Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Tyrosine Protein Kinase Mer Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 68. Global Tyrosine Protein Kinase Mer Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Tyrosine Protein Kinase Mer, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Tyrosine Protein Kinase Mer Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Tyrosine Protein Kinase Mer Production Site of Key Manufacturer
Table 72. Tyrosine Protein Kinase Mer New Entrant and Capacity Expansion Plans
Table 73. Tyrosine Protein Kinase Mer Mergers & Acquisitions in the Past Five Years
Table 74. Global Tyrosine Protein Kinase Mer Sales by Region (2017-2022) & (K Units)
Table 75. Global Tyrosine Protein Kinase Mer Sales by Region (2023-2028) & (K Units)
Table 76. Global Tyrosine Protein Kinase Mer Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Tyrosine Protein Kinase Mer Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Tyrosine Protein Kinase Mer Sales by Type (2017-2022) & (K Units)
Table 79. Global Tyrosine Protein Kinase Mer Sales by Type (2023-2028) & (K Units)
Table 80. Global Tyrosine Protein Kinase Mer Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Tyrosine Protein Kinase Mer Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Tyrosine Protein Kinase Mer Price by Type (2017-2022) & (US$/Unit)
Table 83. Global Tyrosine Protein Kinase Mer Price by Type (2023-2028) & (US$/Unit)
Table 84. Global Tyrosine Protein Kinase Mer Sales by Application (2017-2022) & (K Units)
Table 85. Global Tyrosine Protein Kinase Mer Sales by Application (2023-2028) & (K Units)
Table 86. Global Tyrosine Protein Kinase Mer Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Tyrosine Protein Kinase Mer Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Tyrosine Protein Kinase Mer Price by Application (2017-2022) & (US$/Unit)
Table 89. Global Tyrosine Protein Kinase Mer Price by Application (2023-2028) & (US$/Unit)
Table 90. North America Tyrosine Protein Kinase Mer Sales by Country (2017-2022) & (K Units)
Table 91. North America Tyrosine Protein Kinase Mer Sales by Country (2023-2028) & (K Units)
Table 92. North America Tyrosine Protein Kinase Mer Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Tyrosine Protein Kinase Mer Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Tyrosine Protein Kinase Mer Sales by Type (2017-2022) & (K Units)
Table 95. North America Tyrosine Protein Kinase Mer Sales by Type (2023-2028) & (K Units)
Table 96. North America Tyrosine Protein Kinase Mer Sales by Application (2017-2022) & (K Units)
Table 97. North America Tyrosine Protein Kinase Mer Sales by Application (2023-2028) & (K Units)
Table 98. Europe Tyrosine Protein Kinase Mer Sales by Country (2017-2022) & (K Units)
Table 99. Europe Tyrosine Protein Kinase Mer Sales by Country (2023-2028) & (K Units)
Table 100. Europe Tyrosine Protein Kinase Mer Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Tyrosine Protein Kinase Mer Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Tyrosine Protein Kinase Mer Sales by Type (2017-2022) & (K Units)
Table 103. Europe Tyrosine Protein Kinase Mer Sales by Type (2023-2028) & (K Units)
Table 104. Europe Tyrosine Protein Kinase Mer Sales by Application (2017-2022) & (K Units)
Table 105. Europe Tyrosine Protein Kinase Mer Sales by Application (2023-2028) & (K Units)
Table 106. Asia-Pacific Tyrosine Protein Kinase Mer Sales by Region (2017-2022) & (K Units)
Table 107. Asia-Pacific Tyrosine Protein Kinase Mer Sales by Region (2023-2028) & (K Units)
Table 108. Asia-Pacific Tyrosine Protein Kinase Mer Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Tyrosine Protein Kinase Mer Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Tyrosine Protein Kinase Mer Sales by Type (2017-2022) & (K Units)
Table 111. Asia-Pacific Tyrosine Protein Kinase Mer Sales by Type (2023-2028) & (K Units)
Table 112. Asia-Pacific Tyrosine Protein Kinase Mer Sales by Application (2017-2022) & (K Units)
Table 113. Asia-Pacific Tyrosine Protein Kinase Mer Sales by Application (2023-2028) & (K Units)
Table 114. South America Tyrosine Protein Kinase Mer Sales by Country (2017-2022) & (K Units)
Table 115. South America Tyrosine Protein Kinase Mer Sales by Country (2023-2028) & (K Units)
Table 116. South America Tyrosine Protein Kinase Mer Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Tyrosine Protein Kinase Mer Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Tyrosine Protein Kinase Mer Sales by Type (2017-2022) & (K Units)
Table 119. South America Tyrosine Protein Kinase Mer Sales by Type (2023-2028) & (K Units)
Table 120. South America Tyrosine Protein Kinase Mer Sales by Application (2017-2022) & (K Units)
Table 121. South America Tyrosine Protein Kinase Mer Sales by Application (2023-2028) & (K Units)
Table 122. Middle East & Africa Tyrosine Protein Kinase Mer Sales by Region (2017-2022) & (K Units)
Table 123. Middle East & Africa Tyrosine Protein Kinase Mer Sales by Region (2023-2028) & (K Units)
Table 124. Middle East & Africa Tyrosine Protein Kinase Mer Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Tyrosine Protein Kinase Mer Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Tyrosine Protein Kinase Mer Sales by Type (2017-2022) & (K Units)
Table 127. Middle East & Africa Tyrosine Protein Kinase Mer Sales by Type (2023-2028) & (K Units)
Table 128. Middle East & Africa Tyrosine Protein Kinase Mer Sales by Application (2017-2022) & (K Units)
Table 129. Middle East & Africa Tyrosine Protein Kinase Mer Sales by Application (2023-2028) & (K Units)
Table 130. Tyrosine Protein Kinase Mer Raw Material
Table 131. Key Manufacturers of Tyrosine Protein Kinase Mer Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Tyrosine Protein Kinase Mer Typical Distributors
Table 135. Tyrosine Protein Kinase Mer Typical Customers
List of Figures
Figure 1. Tyrosine Protein Kinase Mer Picture
Figure 2. Global Tyrosine Protein Kinase Mer Revenue Market Share by Type in 2021
Figure 3. Proto Oncogene c Mer
Figure 4. Receptor Tyrosine Kinase MerTK
Figure 5. MERTK
Figure 6. EC 2.7.10.1
Figure 7. Global Tyrosine Protein Kinase Mer Revenue Market Share by Application in 2021
Figure 8. Oncology
Figure 9. Ophthalmology
Figure 10. Global Tyrosine Protein Kinase Mer Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Tyrosine Protein Kinase Mer Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Tyrosine Protein Kinase Mer Sales (2017-2028) & (K Units)
Figure 13. Global Tyrosine Protein Kinase Mer Price (2017-2028) & (US$/Unit)
Figure 14. Global Tyrosine Protein Kinase Mer Production Capacity (2017-2028) & (K Units)
Figure 15. Global Tyrosine Protein Kinase Mer Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Tyrosine Protein Kinase Mer Market Drivers
Figure 17. Tyrosine Protein Kinase Mer Market Restraints
Figure 18. Tyrosine Protein Kinase Mer Market Trends
Figure 19. Global Tyrosine Protein Kinase Mer Sales Market Share by Manufacturer in 2021
Figure 20. Global Tyrosine Protein Kinase Mer Revenue Market Share by Manufacturer in 2021
Figure 21. Tyrosine Protein Kinase Mer Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Tyrosine Protein Kinase Mer Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Tyrosine Protein Kinase Mer Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Tyrosine Protein Kinase Mer Sales Market Share by Region (2017-2028)
Figure 25. Global Tyrosine Protein Kinase Mer Revenue Market Share by Region (2017-2028)
Figure 26. North America Tyrosine Protein Kinase Mer Revenue (2017-2028) & (USD Million)
Figure 27. Europe Tyrosine Protein Kinase Mer Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Tyrosine Protein Kinase Mer Revenue (2017-2028) & (USD Million)
Figure 29. South America Tyrosine Protein Kinase Mer Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Tyrosine Protein Kinase Mer Revenue (2017-2028) & (USD Million)
Figure 31. Global Tyrosine Protein Kinase Mer Sales Market Share by Type (2017-2028)
Figure 32. Global Tyrosine Protein Kinase Mer Revenue Market Share by Type (2017-2028)
Figure 33. Global Tyrosine Protein Kinase Mer Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Tyrosine Protein Kinase Mer Sales Market Share by Application (2017-2028)
Figure 35. Global Tyrosine Protein Kinase Mer Revenue Market Share by Application (2017-2028)
Figure 36. Global Tyrosine Protein Kinase Mer Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Tyrosine Protein Kinase Mer Sales Market Share by Type (2017-2028)
Figure 38. North America Tyrosine Protein Kinase Mer Sales Market Share by Application (2017-2028)
Figure 39. North America Tyrosine Protein Kinase Mer Sales Market Share by Country (2017-2028)
Figure 40. North America Tyrosine Protein Kinase Mer Revenue Market Share by Country (2017-2028)
Figure 41. United States Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Tyrosine Protein Kinase Mer Sales Market Share by Type (2017-2028)
Figure 45. Europe Tyrosine Protein Kinase Mer Sales Market Share by Application (2017-2028)
Figure 46. Europe Tyrosine Protein Kinase Mer Sales Market Share by Country (2017-2028)
Figure 47. Europe Tyrosine Protein Kinase Mer Revenue Market Share by Country (2017-2028)
Figure 48. Germany Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Tyrosine Protein Kinase Mer Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Tyrosine Protein Kinase Mer Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Tyrosine Protein Kinase Mer Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Tyrosine Protein Kinase Mer Revenue Market Share by Region (2017-2028)
Figure 57. China Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Tyrosine Protein Kinase Mer Sales Market Share by Type (2017-2028)
Figure 64. South America Tyrosine Protein Kinase Mer Sales Market Share by Application (2017-2028)
Figure 65. South America Tyrosine Protein Kinase Mer Sales Market Share by Country (2017-2028)
Figure 66. South America Tyrosine Protein Kinase Mer Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Tyrosine Protein Kinase Mer Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Tyrosine Protein Kinase Mer Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Tyrosine Protein Kinase Mer Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Tyrosine Protein Kinase Mer Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Tyrosine Protein Kinase Mer Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Tyrosine Protein Kinase Mer in 2021
Figure 78. Manufacturing Process Analysis of Tyrosine Protein Kinase Mer
Figure 79. Tyrosine Protein Kinase Mer Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場2022年：市場規模予測（～2028年）
  • チロシンタンパク質ホスファターゼ非受容体タイプ 1のグローバル市場展望 2023年-2029年：AU-2439、CPT-157633、DPM-1001、KQ-791、その他
  • 世界のミトジェン活性化プロテインキナーゼ（MAPK）9市場2022年：市場規模予測（～2028年）
  • Rho関連プロテインキナーゼ1のグローバル市場展望 2023年-2029年：AN-3485、KL-01045、AT-13148、TRX-101、その他
  • プロテインキナーゼCモジュレーターのグローバル市場展望 2023年-2029年：タブレット、ジェル、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19681 )"世界のチロシンプロテインキナーゼマー市場2022年：市場規模予測（～2028年）" (英文：Global Tyrosine Protein Kinase Mer Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。